Document is current
Any future updates will be listed below
-
Authors
Griewing, Sebastian
Teske, Pia
Wichmann, Johannes
Oftring, Zoe
Knitza, Johannes
Keil, Corinna
Tauber, Nikolas
Däumichen, Jule
Potthast, Marc
Wallwiener, Stephanie
Wagner, Uwe
Wallwiener, Markus
Gremke, Niklas
Leyer, Michael
Gehling, Hanna
Kuhn, Sebastian
-
Funding
Funding for this research was provided by:
Clinician Scientist program (SUCCESS-program) of Philipps-University of Marburg and the University Hospital of Giessen and Marburg
Philipps-Universität Marburg
- License Information
-
More Information
Article History
Received: 27 July 2025
Accepted: 21 December 2025
First Online: 20 January 2026
Declarations
:
: N.T. received honoraria for lectures and participation in advisory boards: Novartis, ExactSciences, Pfizer, if-kongress, and Deltamed. Travel grants from Astra Zeneca, Thieme, and Daiichi Sankyo. Non-financial support from Daiichi Sankyo and Thieme. Study support by Novartis. S.G. received a travel grant from AbbVie and honoraria for lectures from Novartis. The remaining authors have no relevant financial or non-financial interests to disclose.
: The Philipps-University Marburg Research Ethics Committee confirmed that no ethical approval was required (reference number: 25–92 ANZ) due to the anonymous and non-interventional nature of the study.
: During the proofreading of this paper, the authors used GPT4o to improve readability; after using this tool, the authors reviewed and revised the content as needed and take full responsibility for the content of the publication.
